Selinexor Support Group Launch - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Selinexor Support Group Launch

Selinexor Support Group Launch  image

Selinexor Support Group Launch

Webinar
event Jan 27, 2021 / 11:00AM - 12:00PM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Are you or a loved one currently taking Selinexor as a part of your myeloma treatment regimen? This is a relatively new drug in the myeloma arsenal and both patients and providers are not very familiar with how to use it in the clinic. We are launching this group to provide support to patients on Selinexor and their caregivers. Hear from Dr. Jatin Shah, CMO of Karyopharm, speak about Selinexor, its approval process, and side effect management. While this event will be a formal presentation, future meetings within this chapter will be more of a casual conversation that will include several patients advocates who will help moderate a group discussion as we cover a wide breadth of Selinexor topics.

Schedule & Agenda

Event panelist Audrey Burton-Bethke
11:00 AM
Introductions
Audrey Burton-Bethke
The purpose of the chapter is introduced. The featured speaker, Dr. Jatin Shah is introduced.
Event panelist Dr. Jatin Shah and Jenny Ahlstrom
11:05 AM
Presentation
Dr. Jatin Shah and Jenny Ahlstrom
Dr. Shah and Jenny details about Selinexor such as what is being learned about side effect management, original FDA approval, and recent approval to move Selinexor into earlier lines of therapy. 
Event panelist Bob Sisneros and Audience
11:40 AM
Questions and Answers
Bob Sisneros and Audience
Our patient advocate, Bob Sisneros, will open the question and answer session with a couple of questions of his own. We then will open up the questions to the audience through the question and answer section and try to answer as many as we can. 

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Robert (Bob) Sisneros
Robert (Bob) Sisneros

Bob was diagnosed with myeloma unexpectedly in 2015 through a traumatic experience. After recovering and a failed SCT, he is working his way through other chemotherapy cocktails. Bob is extremely charismatic, loves his wife and family, and is a coach for the Myeloma Crowd if you would like to connect with him. He believes in the power of hope and is a Patient Advocate for our Selinexor Support Group.

Read Bio
The panelist Jatin Shah, MD
Jatin Shah, MD

Dr. Jatin Shah, M.D. is the Chief Medical Officer and Executive Vice President of Development at Karyopharm Therapeutics and has been since July of 2019. His responsibilities include the development of study protocols and clinical development plans. He prepares the regulatory documents and provides scientific and clinical input to each of the studies. Prior to that, Dr. Shah acted as Senior VP of Clinical Development and VP of Clinical Strategy at Karyopharm Therapeutics. He is the co-founder of the World Health Forum/World Myeloma Forum that was launched in February of 2017. Before those accomplishments, Dr. Shah was Director of the Myeloma Clinical and Translational Research in the Department of Lymphoma/Myeloma Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.